Brian Dorsey, Chief Operating Officer at ARS Pharmaceuticals, Inc. (SPRY), sold 30,000 shares at $13.00 ($390K) on 2024-08-13, disclosed to the SEC on 2024-08-15.
Scheduled sale ($390k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| SPRY | SELL | 2024-08-21 | $750K | — | Filing → |
| APRI | BUY | 2014-12-30 | $11K | — | Filing → |
| SOMX | SELL | 2012-01-04 | $4K | — | Filing → |